These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 35883062)

  • 21. The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.
    Almadhi MA; Abdulrahman A; Sharaf SA; AlSaad D; Stevenson NJ; Atkin SL; AlQahtani MM
    Int J Infect Dis; 2021 Apr; 105():656-661. PubMed ID: 33647516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
    Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
    Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 infection in children and adolescents: a Brazilian experience.
    Santos AORD; Lucarevschi BR; Bajerl MH; Pires LO; Ubriaco DC; Nascimento LFC
    Rev Paul Pediatr; 2022; 40():e2021172. PubMed ID: 35544908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
    Pardo Lledias J; Ayarza L; González-García P; Salmón González Z; Calvo Montes J; Gozalo Marguello M; Hernández Hernández JL; Olmos Martínez JM
    Rev Esp Quimioter; 2020 Dec; 33(6):410-414. PubMed ID: 32935535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes associated with Mu variant infection during the third epidemic peak of COVID-19 in Colombia.
    Álvarez-Díaz DA; Ruiz-Moreno HA; Zapata-Bedoya S; Franco-Muñoz C; Laiton-Donato K; Ferro C; Sepulveda MTH; Pacheco-Montealegre M; Walteros DM; Carrero-Galindo LC; Mercado-Reyes M
    Int J Infect Dis; 2022 Dec; 125():149-152. PubMed ID: 36332905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations.
    Ptasinska A; Whalley C; Bosworth A; Poxon C; Bryer C; Machin N; Grippon S; Wise EL; Armson B; Howson ELA; Goring A; Snell G; Forster J; Mattocks C; Frampton S; Anderson R; Cleary D; Parker J; Boukas K; Graham N; Cellura D; Garratt E; Skilton R; Sheldon H; Collins A; Ahmad N; Friar S; Burns D; Williams T; Godfrey KM; Deans Z; Douglas A; Hill S; Kidd M; Porter D; Kidd SP; Cortes NJ; Fowler V; Williams T; Richter A; Beggs AD
    Clin Microbiol Infect; 2021 Sep; 27(9):1348.e1-1348.e7. PubMed ID: 33901668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between RT-qPCR for SARS-CoV-2 and expanded triage in sputum of symptomatic and asymptomatic COVID-19 subjects in Ecuador.
    Torres A; Fors M; Rivero T; Pantoja K; Ballaz S
    BMC Infect Dis; 2021 Jun; 21(1):558. PubMed ID: 34118895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
    Meyers KJ; Dillman B; Williams C; Jiang J; Clifford N; Miller JL; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
    J Med Virol; 2021 May; 93(5):2925-2931. PubMed ID: 33463731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No secret hiding place? Absence of SARS-CoV-2 on the ocular surface of 1145 hospitalized patients in a pandemic area.
    Rokohl AC; Grajewski RS; Wawer Matos PA; Koch HL; Dewald F; Klein F; Fätkenheuer G; Lehmann C; Cursiefen C; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1605-1608. PubMed ID: 33511435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study.
    O'Neill B; Kalia S; Gill P; Hum S; Moran-Venegas C; Stoller R; Greiver M; Agarwal P; Kirubarajan A; DeKoven S; Eisen D; Pinto A; Dunn S
    CMAJ Open; 2021; 9(4):E1134-E1140. PubMed ID: 34876415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico.
    Fernández-Rojas MA; Luna-Ruiz Esparza MA; Campos-Romero A; Calva-Espinosa DY; Moreno-Camacho JL; Mendlovic F; Plett-Torres T; Alcántar-Fernández J
    Sci Rep; 2022 Mar; 12(1):5241. PubMed ID: 35347208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland.
    Kuchar E; Załęski A; Wronowski M; Krankowska D; Podsiadły E; Brodaczewska K; Lewicka A; Lewicki S; Kieda C; Horban A; Kloc M; Kubiak JZ
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):541-547. PubMed ID: 32986153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
    Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
    CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Source and symptoms of COVID-19 among hospital workers in Milan.
    Mandić-Rajčević S; Masci F; Crespi E; Franchetti S; Longo A; Bollina I; Velocci S; Amorosi A; Baldelli R; Boselli L; Negroni L; Zà A; Orfeo NV; Ortisi G; Centanni S; Colosio C
    Occup Med (Lond); 2020 Dec; 70(9):672-679. PubMed ID: 33269398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs.
    Hartard C; Berger S; Josse T; Schvoerer E; Jeulin H
    Clin Chem Lab Med; 2021 Nov; 59(12):2003-2009. PubMed ID: 34331847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020.
    Bender JK; Brandl M; Höhle M; Buchholz U; Zeitlmann N
    Emerg Infect Dis; 2021 Apr; 27(4):1159-63. PubMed ID: 33600301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outbreak of SARS-CoV-2 infection at a large refugee shelter in Toronto, April 2020: a clinical and epidemiologic descriptive analysis.
    Redditt V; Wright V; Rashid M; Male R; Bogoch I
    CMAJ Open; 2020; 8(4):E819-E824. PubMed ID: 33293331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.